Company / Current Liabilities
Amneal Pharmaceuticals, Inc. Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$881.6M
FY2025
5-year range
$677.2M / $1.1B
FY2021-FY2025
Trend
-22.0%
vs FY2024
Sector context
#28 of 213
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s current liabilities of $882M is higher than 87% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 9 years, ranging from $297M in FY2017 to $1.1B in FY2024.
Based on SEC 10-K filings.
$882M in FY2025 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Increased from $847M to $882M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
-44.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.4%, indicating consistent growth.
- In FY2025, current liabilities decreased 22.0% year-over-year.
- Ranks #28 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $881.6M | -22.0% |
| FY2024 | $1.1B | +33.4% |
| FY2023 | $846.6M | +12.5% |
| FY2022 | $752.8M | +11.2% |
| FY2021 | $677.2M | +0.1% |
| FY2020 | $676.9M | +23.0% |
| FY2019 | $550.4M | -0.6% |
| FY2018 | $553.9M | +86.6% |
| FY2017 | $296.9M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026